Total Liabilities: The total value of all possible claims against the corporation.
Bolt Biotherapeutics, Inc. (BOLT) had Total Liabilities of $27.70M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.01M |
|
$-7.72M |
|
-- |
|
$0.01M |
|
$8.38M |
|
$-8.37M |
|
$0.65M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-8.37M |
|
$-8.28M |
|
1.69M |
|
1.69M |
|
$-4.57 |
|
$-4.57 |
|
| Balance Sheet Financials | |
$20.56M |
|
$0.57M |
|
$19.78M |
|
$40.34M |
|
$7.87M |
|
$18.53M |
|
$19.84M |
|
|
Total Liabilities |
$27.70M |
$12.64M |
|
$12.64M |
|
$12.64M |
|
1.93M |
|
| Cash Flow Statement Financials | |
$-14.56M |
|
$15.70M |
|
$0.03M |
|
$13.44M |
|
$14.60M |
|
$1.16M |
|
$1.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.61 |
|
-- |
|
-- |
|
0.59 |
|
1.47 |
|
100.00% |
|
-167480.00% |
|
-167480.00% |
|
-- |
|
-154400.00% |
|
-154400.00% |
|
$-13.86M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-61.08% |
|
-61.08% |
|
-19.14% |
|
-24.77% |
|
$6.56 |
|
$-8.20 |
|
$-8.61 |
|